Holen Sie sich die Stockscreener-App
0.5354
6.29%
0.0317
Handel nachbörslich:
.53
-0.0054
-1.01%
Schlusskurs vom Vortag:
$0.5037
Offen:
$0.5
24-Stunden-Volumen:
328.25K
Relative Volume:
0.12
Marktkapitalisierung:
$22.37M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-74.56M
KGV:
-0.2923
EPS:
-1.8316
Netto-Cashflow:
$-60.27M
1W Leistung:
+1.46%
1M Leistung:
+31.81%
6M Leistung:
-31.80%
1J Leistung:
-53.04%
1-Tages-Spanne:
$0.4901
$0.5459
1-Wochen-Bereich:
$0.40
$0.565
52-Wochen-Spanne:
$0.2201
$1.25
Rallybio Corp Stock (RLYB) Company Profile
Firmenname
Rallybio Corp
Sektor
Branche
Telefon
203- 859-3820
Adresse
234 CHURCH STREET, NEW HAVEN
Vergleichen Sie RLYB mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RLYB
Rallybio Corp
|
0.5354 | 21.05M | 0 | -74.56M | -60.27M | -1.8316 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 99.42B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.02B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Rallybio Corp Stock (RLYB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-09 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2024-05-15 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-02-07 | Herabstufung | Jefferies | Buy → Hold |
| 2023-04-17 | Eingeleitet | H.C. Wainwright | Buy |
| 2023-04-10 | Eingeleitet | Wedbush | Outperform |
| 2022-12-09 | Eingeleitet | JP Morgan | Overweight |
| 2022-02-22 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2021-08-23 | Eingeleitet | Cowen | Outperform |
| 2021-08-23 | Eingeleitet | Evercore ISI | Outperform |
| 2021-08-23 | Eingeleitet | Jefferies | Buy |
Alle ansehen
Rallybio Corp Aktie (RLYB) Neueste Nachrichten
Can trapped investors hope for a rebound in Rallybio Corporation2025 Earnings Surprises & Low Drawdown Investment Strategies - Newser
Long term hold vs stop loss in Rallybio CorporationTrade Exit Report & Verified Short-Term Trading Plans - Newser
Rallybio’s SWOT analysis: c5 inhibitor stock shifts focus amid pipeline changes - Investing.com
Rallybio Corporation’s volatility index tracking explainedMarket Rally & Weekly Top Stock Performers List - Newser
Momentum divergence signals in Rallybio Corporation chartMarket Trend Review & Reliable Volume Spike Alerts - Newser
How to integrate Rallybio Corporation into portfolio analysis tools [July 2025 Catalysts]Daily Chart Pattern Signals - Newser
Can trapped investors hope for a rebound in Rallybio Corporation [July 2025 Institutional]Safe Entry Zone Tips - Newser
Detecting support and resistance levels for Rallybio CorporationAlpha Stock Picks with Chart Confirmation - Newser
Historical volatility pattern of Rallybio Corporation visualizedQuarterly Market Review & Long Hold Capital Preservation Plans - Newser
Is Rallybio Corporation stock entering bullish territoryMarket Downturn Defense Strategy Analysis - Newser
Rallybio Corporation stock daily chart insightsHigh Accuracy Trade Setup Identification - Newser
Intraday pattern recognizer results for Rallybio CorporationFast Movement Forecast for Trading Success - Newser
What MACD and RSI say about Rallybio CorporationRisk Aware Trading Ideas with Alert Levels - Newser
Price action breakdown for Rallybio CorporationShort-Term Swing Opportunity Summary Sheet - Newser
Is Rallybio Corporation stock a smart retirement pickBottom Fishing Opportunity - newsyoung.net
What machine learning models say about Rallybio CorporationWeekly Entry Signal Based Forecast Tool - Newser
Is a relief rally coming for Rallybio Corporation holdersFuture Growth Stock Forecasting Strategy - Newser
News impact scoring models applied to Rallybio CorporationFree Fast Gaining Stock Screener Report - Newser
Will Rallybio Corporation bounce back from current supportFree Stock Screener With Smart Filters - Newser
Rallybio Corp Q2 2025 Earnings: Net Loss Narrows to $9.7 Million, R&D Expenses Decrease to $6.1 Million, and Strategic Divestiture Extends Cash Runway - AInvest
Should you wait for a breakout in Rallybio CorporationFree Capital Growth With Controlled Risk Picks - Newser
Applying chart zones and confluence areas to Rallybio CorporationWatchlist Summary for Active Day Traders - Newser
Why Rallybio Corporation stock attracts strong analyst attentionWeekly Price Target Forecast and Alerts - Newser
How Rallybio Corporation stock performs during market volatilityFree Chart Driven High Reward Trading Setup - Newser
Rallybio's Narrowing Losses and Industry Outperformance: A Biotech Turnaround Play? - AInvest
Rallybio First Half 2025 Earnings: US$0.43 loss per share, net loss narrows by 46% from 1H 2024. - AInvest
Rallybio First Half 2025 Earnings: US$0.43 loss per share (vs US$0.83 loss in 1H 2024) - Yahoo Finance
What makes Rallybio Corporation stock price move sharplyPattern Breakout Prediction for Short Term - Newser
Rallybio 2025 Q2 Earnings Improved Net Loss by 40.2% - AInvest
Rallybio Corporation Reports Q2 2025 Financial Results - TipRanks
Rallybio Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 - MarketScreener
Rallybio shares fall 3.41% intraday after Q2 revenue decline. - AInvest
Rallybio Corp SEC 10-Q Report - TradingView
Rallybio Q2: RLYB116 confirmatory PK/PD study on track, cash runway into mid-2027. - AInvest
Rallybio Q2 Revenue Down to $0.2mln, Net Loss Narrows to $9.7mln - AInvest
Rallybio Reports Second Quarter 2025 Financial Results and Provides Business Updates - Yahoo Finance
Rallybio Corporation Stock Performance After Earnings: Historical InsightsFree Technical Entry Strategy for Beginners - Newser
Is Rallybio Corporation a Top Dividend Stock to Watch in 2025Free Entry Alert With Low Drawdown Strategy - Newser
What are analysts’ price targets for Rallybio Corporation in the next 12 monthsTrack top-performing stocks effortlessly - Jammu Links News
Why is Rallybio Corporation stock attracting strong analyst attentionUnlock your trading potential with expert tips - Jammu Links News
Using data models to predict Rallybio Corporation stock movementSwing Trade Entry and Exit Point Analysis - Newser
What the charts say about Rallybio Corporation todayPredictive System for Long-Term Stock Forecast - Newser
Is it the right time to buy Rallybio Corporation stockSuperior investment outcomes - Jammu Links News
Is Rallybio Corporation stock overvalued or undervaluedMaximize returns with disciplined investment techniques - Jammu Links News
How volatile is Rallybio Corporation stock compared to the marketTurbocharged investment results - Jammu Links News
What is the dividend policy of Rallybio Corporation stockLightning-fast growth - Jammu Links News
What analysts say about Rallybio Corporation stockUnlock powerful portfolio management tools - Jammu Links News
What are Rallybio Corporation company’s key revenue driversSkyrocketing returns - Jammu Links News
Finanzdaten der Rallybio Corp-Aktie (RLYB)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):